Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model.

@article{Li2018EffectOI,
  title={Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model.},
  author={H S Li and Denise I T Kuok and Martin M. C. Cheung and Mandy M. T. Ng and K C Ng and Kenrie Pui-Yan Hui and Joseph Sriyal Malik Peiris and Michael Chi Wai Chan and John Malcolm Nicholls},
  journal={Antiviral research},
  year={2018},
  volume={155},
  pages={
          89-96
        }
}
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has emerged as a coronavirus infection of humans in the past 5 years. Though confined to certain geographical regions of the world, infection has been associated with a case fatality rate of 35%, and this mortality may be higher in ventilated patients. As there are few readily available animal models… CONTINUE READING